Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort
Alan R. Lifson(University of Minnesota), Brian K. Agan(Henry M. Jackson Foundation), Anne Eaton(University of Minnesota), John H. Powers(Leidos (United States)), Lynn E. Eberly(University of Minnesota), Elizabeth M. Krantz(Louisiana State University), Jason F. Okulicz(Gilead Sciences (United States)), Grace Macalino(Unknown), Anuradha Ganesan(Walter Reed National Military Medical Center), Patricia L. Grambsch(University of Minnesota), Nancy F. Crum‐Cianflone(Henry M. Jackson Foundation)
Cited by 11
Related Papers
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza
|BMC Infectious Diseases|2015|514
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
|Clinical Infectious Diseases|2015|340
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191